Switzerland’s DEA equivalent, the BAG, has officially approved Dr. Peter Oehen’s MAPS-sponsored study evaluating MDMA-assisted psychotherapy as a treatment for subjects suffering from treatment-resistant Posttraumatic Stress Disorder (PTSD). Permission from BAG was the final regulatory hurdle, since Dr. Oehen has already received approval from the Ethics Committee (Switzerland’s IRB equivalent) and SwissMedic (Switzerland’s FDA equivalent).
